BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. Roles of TGF-beta in hepatic fibrosis. Front Biosci. 2002;7:d793-d807. [PMID: 11897555 DOI: 10.2741/gressner] [Cited by in Crossref: 253] [Cited by in F6Publishing: 189] [Article Influence: 12.7] [Reference Citation Analysis]
Number Citing Articles
1 An P, Tian Y, Chen M, Luo H. Ca(2+) /calmodulin- dependent protein kinase II mediates transforming growth factor-β-induced hepatic stellate cells proliferation but not in collagen α1(I) production. Hepatol Res 2012;42:806-18. [PMID: 22414022 DOI: 10.1111/j.1872-034X.2012.00983.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
2 Geng ZM, Jha RK, Li B, Chen C, Li WZ, Zheng JB, Wang L, Huanchen S. Sorafenib inhibition of hepatic stellate cell proliferation in tumor microenvironment of hepatocellular carcinoma: a study of the sorafenib mechanisms. Cell Biochem Biophys 2014;69:717-24. [PMID: 24633454 DOI: 10.1007/s12013-014-9858-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
3 Gressner OA. Intracrine Signaling Mechanisms of Activin A and TGF-β. Activins and Inhibins. Elsevier; 2011. pp. 59-77. [DOI: 10.1016/b978-0-12-385961-7.00004-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
4 Neyzen S, Van de Leur E, Borkham-Kamphorst E, Herrmann J, Hollweg G, Gressner AM, Weiskirchen R. Cryopreservation of hepatic stellate cells. J Hepatol. 2006;44:910-917. [PMID: 16169118 DOI: 10.1016/j.jhep.2005.07.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
5 Kaimori A, Potter J, Kaimori JY, Wang C, Mezey E, Koteish A. Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J Biol Chem. 2007;282:22089-22101. [PMID: 17513865 DOI: 10.1074/jbc.m700998200] [Cited by in Crossref: 254] [Cited by in F6Publishing: 139] [Article Influence: 16.9] [Reference Citation Analysis]
6 Gressner OA. Less Smad2 is good for you! A scientific update on coffee's liver benefits. Hepatology. 2009;50:970-978. [PMID: 19610047 DOI: 10.1002/hep.23097] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
7 Rockey DC. New therapies in hepatitis C virus and chronic liver disease: antifibrotics. Clin Liver Dis 2006;10:881-900. [PMID: 17164123 DOI: 10.1016/j.cld.2006.08.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
8 Shah R, Reyes-Gordillo K, Arellanes-Robledo J, Lechuga CG, Hernández-Nazara Z, Cotty A, Rojkind M, Lakshman MR. TGF-β1 up-regulates the expression of PDGF-β receptor mRNA and induces a delayed PI3K-, AKT-, and p70(S6K) -dependent proliferative response in activated hepatic stellate cells. Alcohol Clin Exp Res. 2013;37:1838-1848. [PMID: 23895226 DOI: 10.1111/acer.12167] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
9 Fang SM, Yao DM, Zhang XL, Yao XX. Seropharmacological effects of Yigankang Decoction and its separated recipe on collagen metabolism and transforming growth factor-beta 1 expression in hepatic stellate cells. Shijie Huaren Xiaohua Zazhi 2009; 17(27): 2773-2777 [DOI: 10.11569/wcjd.v17.i27.2773] [Reference Citation Analysis]
10 Qiu JF, Zhang ZQ, Chen W, Wu ZY. Cystamine ameliorates liver fibrosis induced by carbon tetrachloride via inhibition of tissue transglutaminase. World J Gastroenterol 2007; 13(32): 4328-4332 [PMID: 17708605 DOI: 10.3748/wjg.v13.i32.4328] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
11 Xu D, Wu Y, Liao ZX, Wang H. Protective effect of verapamil on multiple hepatotoxic factors-induced liver fibrosis in rats. Pharmacol Res. 2007;55:280-286. [PMID: 17223571 DOI: 10.1016/j.phrs.2006.12.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
12 Shaker ME, Eisa NH, Elgaml A, El-Mesery A, El-Shafey M, El-Dosoky M, El-Mowafy M, El-Mesery M. Ingestion of mannose ameliorates thioacetamide-induced intrahepatic oxidative stress, inflammation and fibrosis in rats. Life Sci 2021;286:120040. [PMID: 34637794 DOI: 10.1016/j.lfs.2021.120040] [Reference Citation Analysis]
13 Zeng M, Haase AT, Schacker TW. Lymphoid tissue structure and HIV-1 infection: life or death for T cells. Trends Immunol 2012;33:306-14. [PMID: 22613276 DOI: 10.1016/j.it.2012.04.002] [Cited by in Crossref: 80] [Cited by in F6Publishing: 68] [Article Influence: 8.0] [Reference Citation Analysis]
14 Hsieh CC, Fang HL, Lina WC. Inhibitory effect of Solanum nigrum on thioacetamide-induced liver fibrosis in mice. J Ethnopharmacol 2008;119:117-21. [PMID: 18606216 DOI: 10.1016/j.jep.2008.06.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
15 Lin WC, Lin WL. Ameliorative effect of Ganoderma lucidum on carbon tetrachloride-induced liver fibrosis in rats. World J Gastroenterol 2006; 12(2): 265-270 [PMID: 16482628 DOI: 10.3748/wjg.v12.i2.265] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
16 Rockey DC. Hepatic fibrosis, stellate cells, and portal hypertension. Clin Liver Dis. 2006;10:459-479, vii-viii. [PMID: 17162223 DOI: 10.1016/j.cld.2006.08.017] [Cited by in Crossref: 77] [Cited by in F6Publishing: 72] [Article Influence: 5.1] [Reference Citation Analysis]
17 Iredale JP, Thompson A, Henderson NC. Extracellular matrix degradation in liver fibrosis: Biochemistry and regulation. Biochim Biophys Acta. 2013;1832:876-883. [PMID: 23149387 DOI: 10.1016/j.bbadis.2012.11.002] [Cited by in Crossref: 146] [Cited by in F6Publishing: 134] [Article Influence: 14.6] [Reference Citation Analysis]
18 Cho SS, Lee JH, Kim KM, Park EY, Ku SK, Cho IJ, Yang JH, Ki SH. REDD1 attenuates hepatic stellate cell activation and liver fibrosis via inhibiting of TGF-β/Smad signaling pathway. Free Radic Biol Med 2021;176:246-56. [PMID: 34614448 DOI: 10.1016/j.freeradbiomed.2021.10.002] [Reference Citation Analysis]
19 Bedossa P, Paradis V. Approaches for treatment of liver fibrosis in chronic hepatitis C. Clin Liver Dis. 2003;7:195-210. [PMID: 12691467 DOI: 10.1016/s1089-3261(02)00076-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
20 Hung KS, Lee TH, Chou WY, Wu CL, Cho CL, Lu CN, Jawan B, Wang CH. Interleukin-10 gene therapy reverses thioacetamide-induced liver fibrosis in mice. Biochem Biophys Res Commun. 2005;336:324-331. [PMID: 16126171 DOI: 10.1016/j.bbrc.2005.08.085] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 2.4] [Reference Citation Analysis]
21 Song SL, Gong ZJ, Zhang QR, Huang TX. Effects of Chinese traditional compound, JinSanE, on expression of TGF-β1 and TGF-β1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivoWorld J Gastroenterol 2005; 11(15): 2269-2276 [PMID: 15818738 DOI: 10.3748/wjg.v11.i15.2269] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
22 Xiong F, Li CP. Role of forkhead L2 in transforming growth factor-beta /Smad signaling pathway-mediated activation of hepatic stellate cells. Shijie Huaren Xiaohua Zazhi 2009; 17(23): 2396-2399 [DOI: 10.11569/wcjd.v17.i23.2396] [Reference Citation Analysis]
23 Zhou X, Xiong J, Lu S, Luo L, Chen ZL, Yang F, Jin F, Wang Y, Ma Q, Luo YY, Wang YJ, Zhou JB, Liu P, Zhao L. Inhibitory Effect of Corilagin on miR-21-Regulated Hepatic Fibrosis Signaling Pathway. Am J Chin Med 2019;47:1541-69. [PMID: 31752524 DOI: 10.1142/S0192415X19500794] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
24 Wills PJ, Asha VV. Protective mechanism of Lygodium flexuosum extract in treating and preventing carbon tetrachloride induced hepatic fibrosis in rats. Chem Biol Interact 2007;165:76-85. [PMID: 17157831 DOI: 10.1016/j.cbi.2006.10.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
25 Bitencourt S, de Mesquita FC, Caberlon E, da Silva GV, Basso BS, Ferreira GA, de Oliveira JR. Capsaicin induces de-differentiation of activated hepatic stellate cell. Biochem Cell Biol 2012;90:683-90. [DOI: 10.1139/o2012-026] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
26 Nasehi Z, Kheiripour N, Taheri MA, Ardjmand A, Jozi F, Aghadavod E, Doustimotlagh AH, Shahaboddin ME, Siemianowicz K. The Protective Effects of Securigera securidaca Seed Extract on Liver Injury Induced by Bile Duct Ligation in Rats. BioMed Research International 2022;2022:1-12. [DOI: 10.1155/2022/6989963] [Reference Citation Analysis]
27 Gressner OA, Weiskirchen R, Gressner AM. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests. Clin Chim Acta. 2007;381:107-113. [PMID: 17399697 DOI: 10.1016/j.cca.2007.02.038] [Cited by in Crossref: 132] [Cited by in F6Publishing: 120] [Article Influence: 8.8] [Reference Citation Analysis]
28 Dooley S, Hamzavi J, Ciuclan L, Godoy P, Ilkavets I, Ehnert S, Ueberham E, Gebhardt R, Kanzler S, Geier A, Breitkopf K, Weng H, Mertens PR. Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage. Gastroenterology. 2008;135:642-659. [PMID: 18602923 DOI: 10.1053/j.gastro.2008.04.038] [Cited by in Crossref: 189] [Cited by in F6Publishing: 193] [Article Influence: 13.5] [Reference Citation Analysis]
29 Odena G, Bataller R. Fibrogénesis hepática: fisiopatología. Gastroenterología y Hepatología 2012;35:3-9. [DOI: 10.1016/s0210-5705(12)70043-2] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
30 Wang W, Li A, Yan B, Niu S, Tang J, Li X, Du X, Challis GL, Che Y, Sun H, Pu J. LC-MS-Guided Isolation of Penicilfuranone A: A New Antifibrotic Furancarboxylic Acid from the Plant Endophytic Fungus Penicillium sp. sh18. J Nat Prod 2016;79:149-55. [DOI: 10.1021/acs.jnatprod.5b00814] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
31 Zhao C, Dai CL. Role of Kupffer cells in hepatic fibrosis. Shijie Huaren Xiaohua Zazhi 2008; 16(26): 2959-2963 [DOI: 10.11569/wcjd.v16.i26.2959] [Reference Citation Analysis]
32 Bian E, Huang C, Wang H, Chen X, Zhang L, Lv X, Li J. Repression of Smad7 mediated by DNMT1 determines hepatic stellate cell activation and liver fibrosis in rats. Toxicology Letters 2014;224:175-85. [DOI: 10.1016/j.toxlet.2013.10.038] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 5.8] [Reference Citation Analysis]
33 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2003; 11(10): 1601-1605 [DOI: 10.11569/wcjd.v11.i10.1601] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
34 Cong M, Liu T, Wang P, Fan X, Yang A, Bai Y, Peng Z, Wu P, Tong X, Chen J. Antifibrotic effects of a recombinant adeno-associated virus carrying small interfering RNA targeting TIMP-1 in rat liver fibrosis. Am J Pathol. 2013;182:1607-1616. [PMID: 23474083 DOI: 10.1016/j.ajpath.2013.01.036] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
35 Liao M, Lin X, Chen ZN, Li Y, Zhuo L. Effects of cocktail therapy on TGF-β1, COL I and COL III expression in liver fibrosis in rats. Shijie Huaren Xiaohua Zazhi 2010; 18(18): 1867-1872 [DOI: 10.11569/wcjd.v18.i18.1867] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Zhang ZF, Zhang YG, Hu DH, Shi JH, Liu JQ, Zhao ZT, Wang HT, Bai XZ, Cai WX, Zhu HY, Tang CW. Smad interacting protein 1 as a regulator of skin fibrosis in pathological scars. Burns 2011;37:665-72. [PMID: 21236582 DOI: 10.1016/j.burns.2010.12.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
37 Lin WC, Kuo SC, Lin WL, Fang HL, Wang BC. Filtrate of fermented mycelia from Antrodia camphorata reduces liver fibrosis induced by carbon tetrachloride in rats. World J Gastroenterol 2006; 12(15): 2369-2374 [PMID: 16688827 DOI: 10.3748/wjg.v12.i15.2369] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
38 Friedman SL. Liver fibrosis -- from bench to bedside. J Hepatol. 2003;38 Suppl 1:S38-S53. [PMID: 12591185 DOI: 10.1016/s0168-8278(02)00429-4] [Cited by in Crossref: 1077] [Cited by in F6Publishing: 451] [Article Influence: 56.7] [Reference Citation Analysis]
39 Meurer SK, Lahme B, Tihaa L, Weiskirchen R, Gressner AM. N-acetyl-L-cysteine suppresses TGF-beta signaling at distinct molecular steps: the biochemical and biological efficacy of a multifunctional, antifibrotic drug. Biochem Pharmacol 2005;70:1026-34. [PMID: 16098950 DOI: 10.1016/j.bcp.2005.07.001] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 2.5] [Reference Citation Analysis]
40 Hübscher SG. Iron overload, inflammation and fibrosis in genetic haemochromatosis. Journal of Hepatology 2003;38:521-5. [DOI: 10.1016/s0168-8278(03)00078-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
41 Chuang HY, Ng LT, Lin LT, Chang JS, Chen JY, Lin TC, Lin CC. Hydrolysable tannins of tropical almond show antifibrotic effects in TGF-β1-induced hepatic stellate cells. J Sci Food Agric. 2011;91:2777-2784. [PMID: 21725979 DOI: 10.1002/jsfa.4521] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
42 Galal GM, Amin NF, Abdel Hafeez HA, El-Baz MA. Can serum fibrosis markers predict medium/large oesophageal varices in patients with liver cirrhosis? Arab J Gastroenterol 2011;12:62-7. [PMID: 21684475 DOI: 10.1016/j.ajg.2011.04.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
43 Gressner OA. About coffee, cappuccino and connective tissue growth factor-Or how to protect your liver!? Environ Toxicol Pharmacol 2009;28:1-10. [PMID: 21783975 DOI: 10.1016/j.etap.2009.02.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
44 Fu Y, Zheng S, Lin J, Ryerse J, Chen A. Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Mol Pharmacol. 2008;73:399-409. [PMID: 18006644 DOI: 10.1124/mol.107.039818] [Cited by in Crossref: 264] [Cited by in F6Publishing: 253] [Article Influence: 17.6] [Reference Citation Analysis]
45 Yan HJ, Kwon SY, Kim K, Jeong H, Kim Y, Chung WS, Lee J, Jang H. Anti-fibrotic effects of Kyungheechunggan-tang on activated hepatic stellate cells and rat liver. Mol Cell Toxicol 2014;10:411-21. [DOI: 10.1007/s13273-014-0046-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
46 Fujimoto J, Iimuro Y. Carbon Tetrachloride-Induced Hepatotoxicity*. Comprehensive Toxicology. Elsevier; 2010. pp. 437-55. [DOI: 10.1016/b978-0-08-046884-6.01018-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
47 Ruehl M, Erben U, Kim K, Freise C, Dagdelen T, Eisele S, Trowitzsch-Kienast W, Zeitz M, Jia J, Stickel F. Extracts of Lindera obtusiloba induce antifibrotic effects in hepatic stellate cells via suppression of a TGF-beta-mediated profibrotic gene expression pattern. J Nutr Biochem. 2009;20:597-606. [PMID: 18824344 DOI: 10.1016/j.jnutbio.2008.06.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
48 Hui AY, Dannenberg AJ, Sung JJ, Subbaramaiah K, Du B, Olinga P, Friedman SL. Prostaglandin E2 inhibits transforming growth factor beta 1-mediated induction of collagen alpha 1(I) in hepatic stellate cells. J Hepatol. 2004;41:251-258. [PMID: 15288474 DOI: 10.1016/j.jhep.2004.04.033] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 2.9] [Reference Citation Analysis]
49 Xu XB, Leng XS, He ZP, Liang ZQ. Smad4 antisense gene transfer into ito cells and suppressed extracellular matrix production. Shijie Huaren Xiaohua Zazhi 2003; 11(11): 1690-1693 [DOI: 10.11569/wcjd.v11.i11.1690] [Reference Citation Analysis]
50 Tatsukawa H, Kojima S. Recent advances in understanding the roles of transglutaminase 2 in alcoholic steatohepatitis. Cell Biol Int 2010;34:325-34. [DOI: 10.1042/cbi20090130] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
51 Flisiak R, Jaroszewicz J, Łapiński TW, Flisiak I, Rogalska M, Prokopowicz D. Plasma transforming growth factor β1, metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 in acute viral hepatitis type B. Regulatory Peptides 2005;131:54-8. [DOI: 10.1016/j.regpep.2005.06.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
52 Xu T, Pan Z, Dong M, Yu C, Niu Y. Ferulic acid suppresses activation of hepatic stellate cells through ERK1/2 and Smad signaling pathways in vitro. Biochemical Pharmacology 2015;93:49-58. [DOI: 10.1016/j.bcp.2014.10.016] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
53 Järvinen PM, Laiho M. LIM-domain proteins in transforming growth factor β-induced epithelial-to-mesenchymal transition and myofibroblast differentiation. Cellular Signalling 2012;24:819-25. [DOI: 10.1016/j.cellsig.2011.12.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
54 Ha MH, Rao HY, Liu F, Pan XB, Feng B, Chen HS, Wei L. Increased expression of Collagen I and Collagen III induced by HBV in hepatic stellate cells. Shijie Huaren Xiaohua Zazhi 2008; 16(18): 2031-2035 [DOI: 10.11569/wcjd.v16.i18.2031] [Reference Citation Analysis]
55 Poncelet AC, Schnaper HW, Tan R, Liu Y, Runyan CE. Cell phenotype-specific down-regulation of Smad3 involves decreased gene activation as well as protein degradation. J Biol Chem 2007;282:15534-40. [PMID: 17400544 DOI: 10.1074/jbc.M701991200] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
56 Hou J, Tian J, Jiang W, Gao Y, Fu F. Therapeutic effects of SMND-309, a new metabolite of salvianolic acid B, on experimental liver fibrosis. Eur J Pharmacol 2011;650:390-5. [PMID: 20969856 DOI: 10.1016/j.ejphar.2010.10.019] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
57 Wang H, Zhao YP, Gao CF, Ji Q, Gressner AM, Yang ZX, Weiskirchen R. Transforming growth factor beta 1 gene variants increase transcription and are associated with liver cirrhosis in Chinese. Cytokine. 2008;43:20-25. [PMID: 18547814 DOI: 10.1016/j.cyto.2008.04.013] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
58 Eurich D, Bahra M, Boas-knoop S, Lock JF, Golembus J, Neuhaus R, Neuhaus P, Neumann UP. Transforming growth factor β1 polymorphisms and progression of graft fibrosis after liver transplantation for hepatitis C virus--induced liver disease. Liver Transpl 2011;17:279-88. [DOI: 10.1002/lt.22190] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
59 Safadi R, Ohta M, Alvarez CE, Fiel MI, Bansal M, Mehal WZ, Friedman SL. Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes. Gastroenterology. 2004;127:870-882. [PMID: 15362042 DOI: 10.1053/j.gastro.2004.04.062] [Cited by in Crossref: 173] [Cited by in F6Publishing: 163] [Article Influence: 9.6] [Reference Citation Analysis]
60 Liu Y, Meyer C, Müller A, Herweck F, Li Q, Müllenbach R, Mertens PR, Dooley S, Weng HL. IL-13 induces connective tissue growth factor in rat hepatic stellate cells via TGF-β-independent Smad signaling. J Immunol. 2011;187:2814-2823. [PMID: 21804025 DOI: 10.4049/jimmunol.1003260] [Cited by in Crossref: 72] [Cited by in F6Publishing: 74] [Article Influence: 6.5] [Reference Citation Analysis]
61 Shao CH, Chen SL, Dong TF, Chai H, Yu Y, Deng L, Wang Y, Cheng F. Transplantation of bone marrow-derived mesenchymal stem cells after regional hepatic irradiation ameliorates thioacetamide-induced liver fibrosis in rats. J Surg Res. 2014;186:408-416. [PMID: 24071025 DOI: 10.1016/j.jss.2013.08.016] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
62 Arauz J, Moreno MG, Cortés-Reynosa P, Salazar EP, Muriel P. Coffee attenuates fibrosis by decreasing the expression of TGF-β and CTGF in a murine model of liver damage. J Appl Toxicol. 2013;33:970-979. [PMID: 22899499 DOI: 10.1002/jat.2788] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 5.9] [Reference Citation Analysis]
63 Goldberg SR, McKinstry RP, Sykes V, Lanning DA. Rapid closure of midgestational excisional wounds in a fetal mouse model is associated with altered transforming growth factor-beta isoform and receptor expression. J Pediatr Surg 2007;42:966-71; discussion 971-3. [PMID: 17560204 DOI: 10.1016/j.jpedsurg.2007.01.055] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
64 Tiao MM, Wang FS, Huang LT, Chuang JH, Kuo HC, Yang YL, Huang YH. MicroRNA-29a protects against acute liver injury in a mouse model of obstructive jaundice via inhibition of the extrinsic apoptosis pathway. Apoptosis. 2014;19:30-41. [PMID: 24052410 DOI: 10.1007/s10495-013-0909-4] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
65 Westhoff JH, Sawitza I, Keski-oja J, Gressner AM, Breitkopf K. PDGF-BB Induces Expression of LTBP-1 but not TGF-β1 in a Rat Cirrhotic Fat Storing Cell Line. Growth Factors 2009;21:121-30. [DOI: 10.1080/08977190310001637224] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
66 Innes H, Buch S, Hutchinson S, Guha IN, Morling JR, Barnes E, Irving W, Forrest E, Pedergnana V, Goldberg D, Aspinall E, Barclay S, Hayes PC, Dillon J, Nischalke HD, Lutz P, Spengler U, Fischer J, Berg T, Brosch M, Eyer F, Datz C, Mueller S, Peccerella T, Deltenre P, Marot A, Soyka M, McQuillin A, Morgan MY, Hampe J, Stickel F. Genome-Wide Association Study for Alcohol-Related Cirrhosis Identifies Risk Loci in MARC1 and HNRNPUL1. Gastroenterology 2020;159:1276-1289.e7. [PMID: 32561361 DOI: 10.1053/j.gastro.2020.06.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
67 Li Y, Wang W, Jia X, Zhai S, Wang X, Wang Y, Dang S. A Targeted Multiple Antigenic Peptide Vaccine Augments the Immune Response to Self TGF-β1 and Suppresses Ongoing Hepatic Fibrosis. Arch Immunol Ther Exp (Warsz) 2015;63:305-15. [PMID: 25740471 DOI: 10.1007/s00005-015-0333-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
68 Aldaba-Muruato LR, Moreno MG, Hernández-Mercado E, Shibayama M, Muriel P. Secondary biliary cirrhosis in the rat is prevented by decreasing NF-κB nuclear translocation and TGF-β expression using allopurinol, an inhibitor of xanthine oxidase. Can J Physiol Pharmacol. 2012;90:1469-1478. [PMID: 23181275 DOI: 10.1139/y2012-125] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
69 Spitz C, Winkels H, Bürger C, Weber C, Lutgens E, Hansson GK, Gerdes N. Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential. Cell Mol Life Sci 2016;73:901-22. [DOI: 10.1007/s00018-015-2080-2] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 7.9] [Reference Citation Analysis]
70 Schuppan D, Popov Y. Rationale and targets for antifibrotic therapies. Gastroenterol Clin Biol 2009;33:949-57. [PMID: 19726145 DOI: 10.1016/j.gcb.2009.07.021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
71 Tian XP, Yin YY, Li X. Effects and mechanisms of Acremoniumterricola milleretal mycelium on liver fibrosis induced by carbon tetrachloride in rats. Am J Chin Med. 2011;39:537-550. [PMID: 21598420 DOI: 10.1142/s0192415x11009019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
72 Muddu AK, Guha IN, Elsharkawy AM, Mann DA. Resolving fibrosis in the diseased liver: translating the scientific promise to the clinic. Int J Biochem Cell Biol 2007;39:695-714. [PMID: 17110155 DOI: 10.1016/j.biocel.2006.10.006] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 2.2] [Reference Citation Analysis]
73 Gressner AM, Weiskirchen R. The tightrope of therapeutic suppression of active transforming growth factor-beta: high enough to fall deeply? J Hepatol. 2003;39:856-859. [PMID: 14568271 DOI: 10.1016/S0168-8278(03)00432-X] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
74 Tag CG, Mengsteab S, Hellerbrand C, Lammert F, Gressner AM, Weiskirchen R. Analysis of the transforming growth factor-beta1 (TGF-beta1) codon 25 gene polymorphism by LightCycler-analysis in patients with chronic hepatitis C infection. Cytokine. 2003;24:173-181. [PMID: 14596813 DOI: 10.1016/j.cyto.2003.08.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
75 Lang Q, Liu Q, Xu N, Qian KL, Qi JH, Sun YC, Xiao L, Shi XF. The antifibrotic effects of TGF-β1 siRNA on hepatic fibrosis in rats. Biochem Biophys Res Commun. 2011;409:448-453. [PMID: 21600192 DOI: 10.1016/j.bbrc.2011.05.023] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 3.7] [Reference Citation Analysis]
76 Xu MY, Hu JJ, Shen J, Wang ML, Zhang QQ, Qu Y, Lu LG. Stat3 signaling activation crosslinking of TGF-β1 in hepatic stellate cell exacerbates liver injury and fibrosis. Biochim Biophys Acta 2014;1842:2237-45. [PMID: 25092172 DOI: 10.1016/j.bbadis.2014.07.025] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 6.3] [Reference Citation Analysis]
77 van der Poorten D, George J. Disease-specific mechanisms of fibrosis: hepatitis C virus and nonalcoholic steatohepatitis. Clin Liver Dis. 2008;12:805-824, ix. [PMID: 18984468 DOI: 10.1016/j.cld.2008.07.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
78 Burra P, Masier A, Morisco F, Di Leo V, Zorzi M, Senzolo M, Marchini F, Guido M, Canova D, Floreani A, Burroughs A. HCV infection in haemodialysed patients: A role for serum IL-10 and TGF-β1 in liver damage? Digestive and Liver Disease 2008;40:827-33. [DOI: 10.1016/j.dld.2008.01.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
79 de Oliveira SA, de Freitas Souza BS, Sá Barreto EP, Kaneto CM, Neto HA, Azevedo CM, Guimarães ET, de Freitas LA, Ribeiro-Dos-Santos R, Soares MB. Reduction of galectin-3 expression and liver fibrosis after cell therapy in a mouse model of cirrhosis. Cytotherapy 2012;14:339-49. [PMID: 22149185 DOI: 10.3109/14653249.2011.637668] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
80 Schotanus BA, Penning LC, Spee B. Potential of regenerative medicine techniques in canine hepatology. Vet Q 2013;33:207-16. [PMID: 24422896 DOI: 10.1080/01652176.2013.875240] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
81 Choi SH, Jeong SH, Hwang SB. Large hepatitis delta antigen modulates transforming growth factor-beta signaling cascades: implication of hepatitis delta virus-induced liver fibrosis. Gastroenterology. 2007;132:343-357. [PMID: 17241884 DOI: 10.1053/j.gastro.2006.10.038] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
82 Huang Q, Li Y, Zhang S, Huang R, Zheng L, Wei L, He M, Liao M, Li L, Zhuo L, Lin X. Effect and mechanism of methyl helicterate isolated from Helicteres angustifolia (Sterculiaceae) on hepatic fibrosis induced by carbon tetrachloride in rats. J Ethnopharmacol 2012;143:889-95. [PMID: 22967666 DOI: 10.1016/j.jep.2012.08.018] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
83 He YT, Liu DW, Ding LY, Li Q, Xiao YH. Therapeutic effects and molecular mechanisms of anti-fibrosis herbs and selenium on rats with hepatic fibrosis. World J Gastroenterol 2004; 10(5): 703-706 [PMID: 14991942 DOI: 10.3748/wjg.v10.i5.703] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
84 Yang R, Gao N, Chang Q, Meng X, Wang W. The role of IDO, IL-10, and TGF-β in the HCV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. J Med Virol 2019;91:265-71. [PMID: 29611873 DOI: 10.1002/jmv.25083] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
85 Wu YJ, Cai WM, Li Q, Liu Y, Shen H, Mertens PR, Dooley S, Weng HL. Long-term antifibrotic action of interferon-γ treatment in patients with chronic hepatitis B virus infection. Hepatobiliary Pancreat Dis Int 2011;10:151-7. [PMID: 21459721 DOI: 10.1016/s1499-3872(11)60024-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
86 Peterová E, Mrkvicová A, Podmolíková L, Řezáčová M, Kanta J. The role of cytokines TGF-beta1 and FGF-1 in the expression of characteristic markers of rat liver myofibroblasts cultured in three-dimensional collagen gel. Physiol Res 2016;65:661-72. [PMID: 27429124 DOI: 10.33549/physiolres.933092] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
87 Tunçbilek S. Relationship between cytokine gene polymorphisms and chronic hepatitis B virus infection. World J Gastroenterol 2014; 20(20): 6226-6235 [PMID: 24876743 DOI: 10.3748/wjg.v20.i20.6226] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
88 Kikuchi H, Katsuramaki T, Kukita K, Taketani S, Meguro M, Nagayama M, Isobe M, Mizuguchi T, Hirata K. New strategy for the antifibrotic therapy with oral administration of FR260330 (a selective inducible nitric oxide synthase inhibitor) in rat experimental liver cirrhosis. Wound Repair Regen. 2007;15:881-888. [PMID: 18028137 DOI: 10.1111/j.1524-475X.2007.00308.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
89 Fuess LE, Weber JN, den Haan S, Steinel NC, Shim KC, Bolnick DI. Between-population differences in constitutive and infection-induced gene expression in threespine stickleback. Mol Ecol 2021. [PMID: 34582586 DOI: 10.1111/mec.16197] [Reference Citation Analysis]
90 Gressner OA, Lahme B, Rehbein K, Siluschek M, Weiskirchen R, Gressner AM. Pharmacological application of caffeine inhibits TGF-β-stimulated connective tissue growth factor expression in hepatocytes via PPARγ and SMAD2/3-dependent pathways. Journal of Hepatology 2008;49:758-67. [DOI: 10.1016/j.jhep.2008.03.029] [Cited by in Crossref: 85] [Cited by in F6Publishing: 83] [Article Influence: 6.1] [Reference Citation Analysis]
91 Wang L, Yang G, Yuan L, Yang Y, Zhao H, Ho C, Li S. Green Tea Catechins Effectively Altered Hepatic Fibrogenesis in Rats by Inhibiting ERK and Smad1/2 Phosphorylation. J Agric Food Chem 2019;67:5437-45. [DOI: 10.1021/acs.jafc.8b05179] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
92 Shi YF, Fong CC, Zhang Q, Cheung PY, Tzang CH, Wu RS, Yang M. Hypoxia induces the activation of human hepatic stellate cells LX-2 through TGF-beta signaling pathway. FEBS Lett. 2007;581:203-210. [PMID: 17187782 DOI: 10.1016/j.febslet.2006.12.010] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 3.3] [Reference Citation Analysis]
93 Zhou Z, Park S, Kim JW, Zhao J, Lee M, Choi KC, Lim CW, Kim B. Detrimental effects of nicotine on thioacetamide-induced liver injury in mice. Toxicology Mechanisms and Methods 2017;27:501-10. [DOI: 10.1080/15376516.2017.1323256] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
94 Fidan K, Gonen S, Soylemezoglu O. The association of cytokine gene polymorphism with reflux nephropathy. J Pediatr Urol 2013;9:653-8. [PMID: 22906585 DOI: 10.1016/j.jpurol.2012.07.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
95 Chang ML, Lin YT, Kung HN, Hou YC, Liu JJ, Pan MH, Chen HL, Yu CH, Tsai PJ. A triterpenoid-enriched extract of bitter melon leaves alleviates hepatic fibrosis by inhibiting inflammatory responses in carbon tetrachloride-treated mice. Food Funct 2021;12:7805-15. [PMID: 34231603 DOI: 10.1039/d1fo00884f] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
96 Bian EB, Huang C, Ma TT, Tao H, Zhang H, Cheng C, Lv XW, Li J. DNMT1-mediated PTEN hypermethylation confers hepatic stellate cell activation and liver fibrogenesis in rats. Toxicol Appl Pharmacol. 2012;264:13-22. [PMID: 22841775 DOI: 10.1016/j.taap.2012.06.022] [Cited by in Crossref: 87] [Cited by in F6Publishing: 90] [Article Influence: 8.7] [Reference Citation Analysis]
97 Janoschek N, van de Leur E, Gressner AM, Weiskirchen R. Induction of cell death in activated hepatic stellate cells by targeted gene expression of the thymidine kinase/ganciclovir system. Biochem Biophys Res Commun. 2004;316:1107-1115. [PMID: 15044099 DOI: 10.1016/j.bbrc.2004.02.147] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
98 Gressner OA, Lahme B, Gressner AM. Gc-globulin (vitamin D binding protein) is synthesized and secreted by hepatocytes and internalized by hepatic stellate cells through Ca(2+)-dependent interaction with the megalin/gp330 receptor. Clin Chim Acta 2008;390:28-37. [PMID: 18194670 DOI: 10.1016/j.cca.2007.12.011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
99 Oertelt-Prigione S, Mao TK, Selmi C, Tsuneyama K, Ansari AA, Coppel RL, Invernizzi P, Podda M, Gershwin ME. Impaired indoleamine 2,3-dioxygenase production contributes to the development of autoimmunity in primary biliary cirrhosis. Autoimmunity 2008;41:92-9. [PMID: 18176870 DOI: 10.1080/08916930701619730] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
100 Choi SH, Jeong SH, Hwang SB. Large hepatitis delta antigen modulates transforming growth factor-beta signaling cascades: implication of hepatitis delta virus-induced liver fibrosis. Gastroenterology 2007;132:343-57. [PMID: 17241884 DOI: 10.1053/j.gastro.2006.10.038] [Reference Citation Analysis]
101 Gressner AM, Lahme B, Meurer SK, Gressner O, Weiskirchen R. Variable expression of cystatin C in cultured trans-differentiating rat hepatic stellate cells. World J Gastroenterol 2006; 12(5): 731-738 [PMID: 16521186 DOI: 10.3748/wjg.v12.i5.731] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
102 Friedman SL. Hepatic fibrosis-overview. Toxicology. 2008;254:120-129. [PMID: 18662740 DOI: 10.1016/j.tox.2008.06.013] [Cited by in Crossref: 240] [Cited by in F6Publishing: 227] [Article Influence: 17.1] [Reference Citation Analysis]
103 Migault M, Sapkota S, Bracken CP. Transcriptional and post-transcriptional control of epithelial-mesenchymal plasticity: why so many regulators? Cell Mol Life Sci 2022;79. [DOI: 10.1007/s00018-022-04199-0] [Reference Citation Analysis]
104 Zhou Z, Deng L, Hu L, Ren Q, Cai Z, Wang B, Li Z, Zhang L. Hepatoprotective effects of ZLY16, a dual peroxisome proliferator-activated receptor α/δ agonist, in rodent model of nonalcoholic steatohepatitis. Eur J Pharmacol 2020;882:173300. [PMID: 32592770 DOI: 10.1016/j.ejphar.2020.173300] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
105 Ananiev J, Penkova M, Tchernev G, Gulubova M. Macrophages, TGF-β1 expression and iron deposition in development of NASH. Open Medicine 2012;7:599-603. [DOI: 10.2478/s11536-012-0033-9] [Reference Citation Analysis]
106 Geng Y, Wang J, Sun Q, Xie M, Lu Z, Xu H, Shi J, Xu Z. Identification of antrodin B from Antrodia camphorata as a new anti-hepatofibrotic compound using a rapid cell screening method and biological evaluation: Identification of antrodin B for liver fibrosis. Hepatol Res 2016;46:E15-25. [DOI: 10.1111/hepr.12516] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
107 Coletta RD, Graner E. Hereditary Gingival Fibromatosis: A Systematic Review. Journal of Periodontology 2006;77:753-64. [DOI: 10.1902/jop.2006.050379] [Cited by in Crossref: 82] [Cited by in F6Publishing: 64] [Article Influence: 5.1] [Reference Citation Analysis]
108 Armutcu F, Akyol S, Ucar F, Erdogan S, Akyol O. Markers in Nonalcoholic Steatohepatitis. Elsevier; 2013. pp. 67-125. [DOI: 10.1016/b978-0-12-407680-8.00004-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 França MERD, Rocha SWS, Oliveira WH, Santos LA, de Oliveira AGV, Barbosa KPS, Nunes AKS, Rodrigues GB, Lós DB, Peixoto CA. Diethylcarbamazine attenuates the expression of pro-fibrogenic markers and hepatic stellate cells activation in carbon tetrachloride-induced liver fibrosis. Inflammopharmacol 2018;26:599-609. [DOI: 10.1007/s10787-017-0329-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
110 Shi H, Dong L, Zhang Y, Bai Y, Zhao J, Zhang L. Protective effect of a coffee preparation (Nescafe pure®) against carbon tetrachloride-induced liver fibrosis in rats. Clinical Nutrition 2010;29:399-405. [DOI: 10.1016/j.clnu.2009.12.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
111 Wegner K, Bachmann A, Schad JU, Lucarelli P, Sahle S, Nickel P, Meyer C, Klingmüller U, Dooley S, Kummer U. Dynamics and feedback loops in the transforming growth factor β signaling pathway. Biophys Chem 2012;162:22-34. [PMID: 22284904 DOI: 10.1016/j.bpc.2011.12.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
112 Huang CY, Chung CL, Hu TH, Chen JJ, Liu PF, Chen CL. Recent progress in TGF-β inhibitors for cancer therapy. Biomed Pharmacother 2021;134:111046. [PMID: 33341049 DOI: 10.1016/j.biopha.2020.111046] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
113 Wei YF, Peng Y, Xie HY, Zhao TJ. Advances in anti-fibrosis at the molecular level based on hepatic stellate cells. Shijie Huaren Xiaohua Zazhi 2009; 17(17): 1745-1748 [DOI: 10.11569/wcjd.v17.i17.1745] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
114 Fan S, Chen HN, Wang CJ, Tseng WC, Hsu HK, Weng CF. Toona sinensis Roem (Meliaceae) leaf extract alleviates liver fibrosis via reducing TGFbeta1 and collagen. Food Chem Toxicol 2007;45:2228-36. [PMID: 17629604 DOI: 10.1016/j.fct.2007.05.022] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
115 Bona S, Moreira AJ, Rodrigues GR, Cerski CT, da Silveira TR, Marroni CA, Marroni NP. Diethylnitrosamine-induced cirrhosis in Wistar rats: an experimental feasibility study. Protoplasma 2015;252:825-33. [DOI: 10.1007/s00709-014-0719-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
116 Chen W, Chen C, Liao J, Mao FC. Chromium attenuates hepatic damage in a rat model of chronic cholestasis. Life Sciences 2009;84:606-14. [DOI: 10.1016/j.lfs.2009.02.003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
117 Liao M, Li Y, Shu W. Effects of genistein on cell proliferation and TGF-β1, MMP-2 and TIMP-2 expression in rat hepatic stellate cells. Shijie Huaren Xiaohua Zazhi 2010; 18(3): 229-233 [DOI: 10.11569/wcjd.v18.i3.229] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
118 Mazhari S, Gitiara A, Baghaei K, Hatami B, Rad RE, Asadirad A, Joharchi K, Tokhanbigli S, Hashemi SM, Łos MJ, Aghdaei HA, Zali MR, Ghavami S. Therapeutic potential of bone marrow-derived mesenchymal stem cells and imatinib in a rat model of liver fibrosis. Eur J Pharmacol 2020;882:173263. [PMID: 32535098 DOI: 10.1016/j.ejphar.2020.173263] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
119 Chen WY, Lin SY, Pan HC, Liao SL, Chuang YH, Yen YJ, Lin SY, Chen CJ. Beneficial effect of docosahexaenoic acid on cholestatic liver injury in rats. J Nutr Biochem 2012;23:252-64. [PMID: 21497498 DOI: 10.1016/j.jnutbio.2010.11.022] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
120 Purps O, Lahme B, Gressner AM, Meindl-Beinker NM, Dooley S. Loss of TGF-beta dependent growth control during HSC transdifferentiation. Biochem Biophys Res Commun. 2007;353:841-847. [PMID: 17204247 DOI: 10.1016/j.bbrc.2006.12.125] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
121 Li Y, Liu L, Wang B, Wang J, Chen D. Hematocrit is associated with fibrosis in patients with nonalcoholic steatohepatitis: . European Journal of Gastroenterology & Hepatology 2014;26:332-8. [DOI: 10.1097/meg.0000000000000015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
122 Feng FZ, Gong WY, Li SY, Deng YH. Inhibitory Effect of Resveratrol on LPS-induced Glomerular Mesangial Cells Proliferation and TGF-β1 Expression via Sphingosine Kinase 1 Pathway. Chin J Integr Med 2022. [PMID: 35258781 DOI: 10.1007/s11655-022-3530-y] [Reference Citation Analysis]
123 Uchio K, Graham M, Dean NM, Rosenbaum J, Desmoulière A. Down-regulation of connective tissue growth factor and type I collagen mRNA expression by connective tissue growth factor antisense oligonucleotide during experimental liver fibrosis: Wound Repair and Regeneration. Wound Repair and Regeneration 2004;12:60-6. [DOI: 10.1111/j.1067-1927.2004.012112.x-1] [Cited by in Crossref: 48] [Cited by in F6Publishing: 30] [Article Influence: 3.7] [Reference Citation Analysis]
124 Yu FX, Su LF, Dai CL, Wang Y, Teng YY, Fu JH, Zhang QY, Tang YH. Inhibition of pancreatic stellate cell activity by adipose-derived stem cells. Hepatobiliary Pancreat Dis Int 2015;14:215-21. [PMID: 25865696 DOI: 10.1016/s1499-3872(14)60283-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
125 Lim AR, Ghajar CM. Thorny ground, rocky soil: Tissue-specific mechanisms of tumor dormancy and relapse. Semin Cancer Biol 2021:S1044-579X(21)00135-8. [PMID: 33979673 DOI: 10.1016/j.semcancer.2021.05.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
126 Schulze-Krebs A, Preimel D, Popov Y, Bartenschlager R, Lohmann V, Pinzani M, Schuppan D. Hepatitis C virus-replicating hepatocytes induce fibrogenic activation of hepatic stellate cells. Gastroenterology. 2005;129:246-258. [PMID: 16012951 DOI: 10.1053/j.gastro.2005.03.089] [Cited by in Crossref: 107] [Cited by in F6Publishing: 96] [Article Influence: 6.3] [Reference Citation Analysis]
127 Bian EB, Huang C, Wang H, Wu BM, Zhang L, Lv XW, Li J. DNA methylation: new therapeutic implications for hepatic fibrosis. Cell Signal. 2013;25:355-358. [PMID: 23085259 DOI: 10.1016/j.cellsig.2012.10.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
128 Prosser CC, Yen RD, Wu J. Molecular therapy for hepatic injury and fibrosis: Where are we? World J Gastroenterol 2006; 12(4): 509-515 [PMID: 16489661 DOI: 10.3748/wjg.v12.i4.509] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 56] [Article Influence: 3.4] [Reference Citation Analysis]
129 Jiroutova A, Slavkovsky R, Cermakova M, Majdiakova L, Hanovcova I, Bolehovska R, Hajzlerova M, Radilova H, Ruszova E, Kanta J. Expression of mRNAs related to connective tissue metabolism in rat hepatic stellate cells and myofibroblasts. Experimental and Toxicologic Pathology 2007;58:263-73. [DOI: 10.1016/j.etp.2006.06.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
130 Chen YW, Li DG, Wu JX, Chen YW, Lu HM. Tetrandrine inhibits activation of rat hepatic stellate cells stimulated by transforming growth factor-beta in vitro via up-regulation of Smad 7. J Ethnopharmacol. 2005;100:299-305. [PMID: 15905052 DOI: 10.1016/j.jep.2005.03.027] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
131 Hauff P, Gottwald U, Ocker M. Early to Phase II drugs currently under investigation for the treatment of liver fibrosis. Expert Opin Investig Drugs. 2015;24:309-327. [PMID: 25547844 DOI: 10.1517/13543784.2015.997874] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
132 Murata T, Ohshima T, Yamaji M, Hosaka M, Miyanari Y, Hijikata M, Shimotohno K. Suppression of hepatitis C virus replicon by TGF-beta. Virology. 2005;331:407-417. [PMID: 15629783 DOI: 10.1016/j.virol.2004.10.036] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 3.1] [Reference Citation Analysis]
133 Dooley S, Hamzavi J, Breitkopf K, Wiercinska E, Said HM, Lorenzen J, Ten Dijke P, Gressner AM. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology. 2003;125:178-191. [PMID: 12851882 DOI: 10.1016/s0016-5085(03)00666-8] [Cited by in Crossref: 262] [Cited by in F6Publishing: 123] [Article Influence: 13.8] [Reference Citation Analysis]
134 Stefano JT, Cogliati B, Santos F, Lima VM, Mazo DC, Matte U, Alvares-da-Silva MR, Silveira TR, Carrilho FJ, Oliveira CP. S-Nitroso-N-acetylcysteine induces de-differentiation of activated hepatic stellate cells and promotes antifibrotic effects in vitro. Nitric Oxide 2011;25:360-5. [PMID: 21820071 DOI: 10.1016/j.niox.2011.07.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
135 Shi H, Dong L, Bai Y, Zhao J, Zhang Y, Zhang L. Chlorogenic acid against carbon tetrachloride-induced liver fibrosis in rats. Eur J Pharmacol. 2009;623:119-124. [PMID: 19786014 DOI: 10.1016/j.ejphar.2009.09.026] [Cited by in Crossref: 62] [Cited by in F6Publishing: 59] [Article Influence: 4.8] [Reference Citation Analysis]
136 Goldberg SR, Diegelmann RF. Wound Healing Primer. Critical Care Nursing Clinics of North America 2012;24:165-78. [DOI: 10.1016/j.ccell.2012.03.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
137 Ma L, Zeng Y, Wei J, Yang D, Ding G, Liu J, Shang J, Kang Y, Ji X. Knockdown of LOXL1 inhibits TGF-β1-induced proliferation and fibrogenesis of hepatic stellate cells by inhibition of Smad2/3 phosphorylation. Biomed Pharmacother 2018;107:1728-35. [PMID: 30257391 DOI: 10.1016/j.biopha.2018.08.156] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
138 Chen YW, Wu JX, Chen YW, Li DG, Lu HM. Tetrandrine inhibits activation of rat hepatic stellate cells in vitro via transforming growth factor-β signaling. World J Gastroenterol 2005; 11(19): 2922-2926 [PMID: 15902729 DOI: 10.3748/wjg.v11.i19.2922] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
139 Ai ZB, Zhang RH, Yan GH. A modified recipe of Turtle Shell Decoction reduces experimental hepatic fibrosis in rats. Shijie Huaren Xiaohua Zazhi 2011; 19(1): 13-18 [DOI: 10.11569/wcjd.v19.i1.13] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
140 Peng Q, Chunfang G, Meng F, Qiang J, Yunpeng Z, Yan L, Xiaojuan S. Establishment of a real-time PCR for quantifying transforming growth factor beta1 in blood of hepatocellular carcinoma patients. Journal of Medical Colleges of PLA 2008;23:228-36. [DOI: 10.1016/s1000-1948(08)60047-7] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
141 Kongtasai T, Paepe D, Meyer E, Mortier F, Marynissen S, Stammeleer L, Defauw P, Daminet S. Renal biomarkers in cats: A review of the current status in chronic kidney disease. J Vet Intern Med 2022. [PMID: 35218249 DOI: 10.1111/jvim.16377] [Reference Citation Analysis]
142 Kono T, Asama T, Chisato N, Ebisawa Y, Okayama T, Imai K, Karasaki H, Furukawa H, Yoneda M. Polaprezinc prevents ongoing thioacetamide-induced liver fibrosis in rats. Life Sciences 2012;90:122-30. [DOI: 10.1016/j.lfs.2011.10.022] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
143 Meurer SK, Tihaa L, Lahme B, Gressner AM, Weiskirchen R. Identification of endoglin in rat hepatic stellate cells: new insights into transforming growth factor beta receptor signaling. J Biol Chem. 2005;280:3078-3087. [PMID: 15537649 DOI: 10.1074/jbc.m405411200] [Cited by in Crossref: 40] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
144 Liao M, Mo CF, Zhou Y, He M, Zhuo L. Alterations in fibrosis-related gene expression and proteomic expression profile in rat hepatic stellate cells exposed to the cocktail. Shijie Huaren Xiaohua Zazhi 2011; 19(17): 1780-1784 [DOI: 10.11569/wcjd.v19.i17.1780] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
145 Elsammak MY, Amin GM, Khalil GM, Ragab WS, Abaza MM. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis. Clin Biochem. 2006;39:623-629. [PMID: 16624274 DOI: 10.1016/j.clinbiochem.2006.01.022] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
146 Muriel P, Arauz J. Coffee and liver diseases. Fitoterapia 2010;81:297-305. [DOI: 10.1016/j.fitote.2009.10.003] [Cited by in Crossref: 65] [Cited by in F6Publishing: 46] [Article Influence: 5.4] [Reference Citation Analysis]
147 Ota T, Takamura T, Kurita S, Matsuzawa N, Kita Y, Uno M, Akahori H, Misu H, Sakurai M, Zen Y. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis. Gastroenterology. 2007;132:282-293. [PMID: 17241878 DOI: 10.1053/j.gastro.2006.10.014] [Cited by in Crossref: 161] [Cited by in F6Publishing: 164] [Article Influence: 10.1] [Reference Citation Analysis]
148 Wang H, Che J, Cui K, Zhuang W, Li H, Sun J, Chen J, Wang C. Schisantherin A ameliorates liver fibrosis through TGF-β1mediated activation of TAK1/MAPK and NF-κB pathways in vitro and in vivo. Phytomedicine 2021;88:153609. [PMID: 34126414 DOI: 10.1016/j.phymed.2021.153609] [Reference Citation Analysis]
149 Sunbul M, Agirbasli M, Durmus E, Kivrak T, Akin H, Aydin Y, Ergelen R, Yilmaz Y. Arterial stiffness in patients with non-alcoholic fatty liver disease is related to fibrosis stage and epicardial adipose tissue thickness. Atherosclerosis. 2014;237:490-493. [PMID: 25463079 DOI: 10.1016/j.atherosclerosis.2014.10.004] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
150 Serviddio G, Blonda M, Bellanti F, Villani R, Iuliano L, Vendemiale G. Oxysterols and redox signaling in the pathogenesis of non-alcoholic fatty liver disease. Free Radical Research 2013;47:881-93. [DOI: 10.3109/10715762.2013.835048] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
151 Dan J, Gao P, Shen L, Huang HY, Yu ZY. Expression and its significance of connective tissue growth factor and transforming growth factorβ1 in hepatic tissues of non-alcoholic steatohepatitis. Shijie Huaren Xiaohua Zazhi 2008; 16(32): 3637-3641 [DOI: 10.11569/wcjd.v16.i32.3637] [Reference Citation Analysis]
152 Yang YJ, Huang F, Hu J, Ma L, Li ZW. Effect of interleukin-10 on TGF-β1-induced CTGF expression in hepatic stellate cells. Shijie Huaren Xiaohua Zazhi 2008; 16(19): 2154-2157 [DOI: 10.11569/wcjd.v16.i19.2154] [Reference Citation Analysis]
153 Hong SW, Jung KH, Lee HS, Zheng HM, Choi MJ, Lee C, Hong SS. Suppression by fucoidan of liver fibrogenesis via the TGF-β/Smad pathway in protecting against oxidative stress. Biosci Biotechnol Biochem 2011;75:833-40. [PMID: 21597183 DOI: 10.1271/bbb.100599] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
154 Winau F, Hegasy G, Weiskirchen R, Weber S, Cassan C, Sieling PA, Modlin RL, Liblau RS, Gressner AM, Kaufmann SH. Ito Cells Are Liver-Resident Antigen-Presenting Cells for Activating T Cell Responses. Immunity 2007;26:117-29. [DOI: 10.1016/j.immuni.2006.11.011] [Cited by in Crossref: 278] [Cited by in F6Publishing: 259] [Article Influence: 18.5] [Reference Citation Analysis]
155 Machado MV, Diehl AM. Liver renewal: detecting misrepair and optimizing regeneration. Mayo Clin Proc 2014;89:120-30. [PMID: 24388030 DOI: 10.1016/j.mayocp.2013.10.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
156 Borthwick LA, Wynn TA. IL-13 and TGF-β1: Core Mediators of Fibrosis. Curr Pathobiol Rep 2015;3:273-82. [DOI: 10.1007/s40139-015-0091-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
157 Zhan L, Huang C, Meng XM, Song Y, Wu XQ, Yang Y, Li J. Hypoxia-inducible factor-1alpha in hepatic fibrosis: A promising therapeutic target. Biochimie. 2015;108:1-7. [PMID: 25447141 DOI: 10.1016/j.biochi.2014.10.013] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
158 Galicia-Moreno M, Favari L, Muriel P. Trolox mitigates fibrosis in a bile duct ligation model. Fundam Clin Pharmacol 2013;27:308-18. [PMID: 22211361 DOI: 10.1111/j.1472-8206.2011.01020.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
159 Tu X, Zheng X, Li H, Cao Z, Chang H, Luan S, Zhu J, Chen J, Zang Y, Zhang J. MicroRNA-30 Protects Against Carbon Tetrachloride-induced Liver Fibrosis by Attenuating Transforming Growth Factor Beta Signaling in Hepatic Stellate Cells. Toxicol Sci. 2015;146:157-169. [PMID: 25912033 DOI: 10.1093/toxsci/kfv081] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
160 Snowdon VK, Fallowfield JA. Models and mechanisms of fibrosis resolution. Alcohol Clin Exp Res. 2011;35:794-799. [PMID: 21284668 DOI: 10.1111/j.1530-0277.2010.01400.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
161 Liu YG, Lu JH, Wang XX, Yang JL, Lang ZW, Meng X, Zhang LJ, Sun L, Zhang SJ, Li JQ, Song CZ. Influence of HBcAg in liver cell plasma on expression of transforming growth factor-beta 1 in liver tissue of low-grade chronic hepatitis B patients. World J Gastroenterol 2006; 12(1): 127-129 [PMID: 16440431 DOI: 10.3748/wjg.v12.i1.127] [Reference Citation Analysis]
162 Li JL, Cai WS, Shen F, Feng Z, Zhu GH, Cao J, Xu B. Protease-activated receptor-2 modulates hepatic stellate cell collagen release and apoptotic status. Arch Biochem Biophys 2014;545:162-6. [PMID: 24495782 DOI: 10.1016/j.abb.2014.01.027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
163 Tsukada S, Parsons CJ, Rippe RA. Mechanisms of liver fibrosis. Clin Chim Acta. 2006;364:33-60. [PMID: 16139830 DOI: 10.1016/j.cca.2005.06.014] [Cited by in Crossref: 223] [Cited by in F6Publishing: 232] [Article Influence: 13.1] [Reference Citation Analysis]
164 Sarem M, Znaidak R, Macias M, Rey R. [Hepatic stellate cells: it's role in normal and pathological conditions]. Gastroenterol Hepatol. 2006;29:93-101. [PMID: 16448612 DOI: 10.1157/13083906] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 1.3] [Reference Citation Analysis]
165 Bragança de Moraes CM, Bitencourt S, de Mesquita FC, Mello D, de Oliveira LP, da Silva GV, Lorini V, Caberlon E, de Souza Basso B, Schmid J, Ferreira GA, de Oliveira JR. (+)-Catechin attenuates activation of hepatic stellate cells: Catechin attenuates activation of HSCs. Cell Biol Int 2014;38:526-30. [DOI: 10.1002/cbin.10228] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
166 de Mesquita FC, Bitencourt S, Caberlon E, da Silva GV, Basso BS, Schmid J, Ferreira GA, de Oliveira FDS, de Oliveira JR. Fructose-1,6-bisphosphate induces phenotypic reversion of activated hepatic stellate cell. European Journal of Pharmacology 2013;720:320-5. [DOI: 10.1016/j.ejphar.2013.09.067] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
167 Janczewska-Kazek E, Marek B, Kajdaniuk D, Borgiel-Marek H. Effect of interferon alpha and ribavirin treatment on serum levels of transforming growth factor-β1, vascular endothelial growth factor, and basic fibroblast growth factor in patients with chronic hepatitis C. World J Gastroenterol 2006; 12(6): 961-965 [PMID: 16521228 DOI: 10.3748/wjg.v12.i6.961] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
168 Zhang BJ, Xu D, Guo Y, Ping J, Chen LB, Wang H. Protection by and anti-oxidant mechanism of berberine against rat liver fibrosis induced by multiple hepatotoxic factors. Clin Exp Pharmacol Physiol. 2008;35:303-309. [PMID: 17973934 DOI: 10.1111/j.1440-1681.2007.04819.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 3.2] [Reference Citation Analysis]
169 Winau F, Quack C, Darmoise A, Kaufmann SH. Starring stellate cells in liver immunology. Curr Opin Immunol. 2008;20:68-74. [PMID: 18068343 DOI: 10.1016/j.coi.2007.10.006] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 3.7] [Reference Citation Analysis]
170 Weber SN, Wasmuth HE. Liver fibrosis: from animal models to mapping of human risk variants. Best Pract Res Clin Gastroenterol. 2010;24:635-646. [PMID: 20955966 DOI: 10.1016/j.bpg.2010.07.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
171 Safadi R, Zigmond E, Pappo O, Shalev Z, Ilan Y. Amelioration of hepatic fibrosis via beta-glucosylceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution. Int Immunol. 2007;19:1021-1029. [PMID: 17698563 DOI: 10.1093/intimm/dxm069] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
172 Chen YL, Lv J, Ye XL, Sun MY, Xu Q, Liu CH, Min LH, Li HP, Liu P, Ding X. Sorafenib inhibits transforming growth factor β1-mediated epithelial-mesenchymal transition and apoptosis in mouse hepatocytes. Hepatology. 2011;53:1708-1718. [PMID: 21360571 DOI: 10.1002/hep.24254] [Cited by in Crossref: 70] [Cited by in F6Publishing: 71] [Article Influence: 6.4] [Reference Citation Analysis]
173 Ouyang CH, Zhu X, Zhang KH, Dai Y, Chen J, He WH, Li B, Li BM. Effects of ursolic acid on the expression of transforming growth factor-β1 and alpha-smooth muscle actin in fibrotic liver in rats. Shijie Huaren Xiaohua Zazhi 2009; 17(22): 2237-2243 [DOI: 10.11569/wcjd.v17.i22.2237] [Reference Citation Analysis]
174 Klemmer I, Yagi S, Gressner OA. Oral application of 1,7-dimethylxanthine (paraxanthine) attenuates the formation of experimental cholestatic liver fibrosis. Hepatol Res 2011;41:1094-109. [PMID: 22032678 DOI: 10.1111/j.1872-034X.2011.00856.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
175 Liu YK, Shen W. Inhibitive effect of cordyceps sinensis on experimental hepatic fibrosis and its possible mechanism. World J Gastroenterol 2003; 9(3): 529-533 [PMID: 12632512 DOI: 10.3748/wjg.v9.i3.529] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.4] [Reference Citation Analysis]
176 Lan L, Chen YW, Sun C, Liu BW, Sun QL. Transplantation of interleukin 10-modified bone marrow-derived liver stem cells reduces accumulation of extracellular matrix in fibrotic liver in rats. Shijie Huaren Xiaohua Zazhi 2009; 17(22): 2231-2236 [DOI: 10.11569/wcjd.v17.i22.2231] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
177 Devi SL, Viswanathan P, Anuradha CV. Regression of liver fibrosis by taurine in rats fed alcohol: effects on collagen accumulation, selected cytokines and stellate cell activation. Eur J Pharmacol 2010;647:161-70. [PMID: 20813107 DOI: 10.1016/j.ejphar.2010.08.011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
178 Herrmann J, Haas U, Gressner AM, Weiskirchen R. TGF-β up-regulates serum response factor in activated hepatic stellate cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2007;1772:1250-7. [DOI: 10.1016/j.bbadis.2007.10.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
179 Wang H, Mengsteab S, Tag CG, Gao CF, Hellerbrand C, Lammert F, Gressner AM, Weiskirchen R. Transforming growth factor-β1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection. World J Gastroenterol 2005; 11(13): 1929-1936 [PMID: 15800982 DOI: 10.3748/wjg.v11.i13.1929] [Cited by in CrossRef: 58] [Cited by in F6Publishing: 57] [Article Influence: 3.4] [Reference Citation Analysis]
180 Wells RG. Mechanisms of liver fibrosis: New insights into an old problem. Drug Discovery Today: Disease Mechanisms 2006;3:489-95. [DOI: 10.1016/j.ddmec.2006.10.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
181 Li C, Jiang W, Zhu H, Hou J. RETRACTED: Antifibrotic effects of protocatechuic aldehyde on experimental liver fibrosis. Pharmaceutical Biology 2011;50:413-9. [DOI: 10.3109/13880209.2011.608193] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
182 Pan P, Lin S, Wang Y, Chen W, Chuang Y, Wu C, Chen C. Protective effects of rutin on liver injury induced by biliary obstruction in rats. Free Radical Biology and Medicine 2014;73:106-16. [DOI: 10.1016/j.freeradbiomed.2014.05.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 5.5] [Reference Citation Analysis]
183 Caja L, Bertran E, Campbell J, Fausto N, Fabregat I. The transforming growth factor-beta (TGF-β) mediates acquisition of a mesenchymal stem cell-like phenotype in human liver cells. J Cell Physiol 2011;226:1214-23. [DOI: 10.1002/jcp.22439] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 6.8] [Reference Citation Analysis]
184 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2003; 11(10): 1572-1575 [DOI: 10.11569/wcjd.v11.i10.1572] [Reference Citation Analysis]
185 Gressner OA, Gao C. Monitoring fibrogenic progression in the liver. Clin Chim Acta. 2014;433:111-122. [PMID: 24607331 DOI: 10.1016/j.cca.2014.02.021] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
186 Llorente-Cortes V, Barbarigo V, Badimon L. Low density lipoprotein receptor-related protein 1 modulates the proliferation and migration of human hepatic stellate cells. J Cell Physiol 2012;227:3528-33. [PMID: 22392894 DOI: 10.1002/jcp.24080] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
187 Lin H, Huang YH, Li YL, Fu BY, Wang BY. KangXian FuFang I inhibits acetaldehyde-stimulated extracellular matrix synthesis and cytokine secretion in cultured hepatic stellate cells. Shijie Huaren Xiaohua Zazhi 2011; 19(17): 1826-1829 [DOI: 10.11569/wcjd.v19.i17.1826] [Reference Citation Analysis]
188 Goldberg SR, Diegelmann RF. Wound Healing Primer. Surgical Clinics of North America 2010;90:1133-46. [DOI: 10.1016/j.suc.2010.08.003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
189 Guo W, Bai X, Han Y, Xu L, Liu W, Zhang G, Li J, Fan Z, Wang H. Expressions of TGF-β1 and MMP-9 in a guinea pig model of tympanosclerosis: possible role in the pathogenesis of this disorder. Laryngoscope 2012;122:2037-42. [PMID: 22777961 DOI: 10.1002/lary.23415] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
190 Sun WY, Wei W, Wu L, Gui SY, Wang H. Effects and mechanisms of extract from Paeonia lactiflora and Astragalus membranaceus on liver fibrosis induced by carbon tetrachloride in rats. J Ethnopharmacol 2007;112:514-23. [PMID: 17574357 DOI: 10.1016/j.jep.2007.04.005] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
191 He J, Gong J, Ding Q, Tan Q, Han P, Liu J, Zhou Z, Tu W, Xia Y, Yan W, Tian D. Suppressive effect of SATB1 on hepatic stellate cell activation and liver fibrosis in rats. FEBS Lett 2015;589:1359-68. [PMID: 25896016 DOI: 10.1016/j.febslet.2015.04.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
192 Oertelt S, Lian ZX, Cheng CM, Chuang YH, Padgett KA, He XS, Ridgway WM, Ansari AA, Coppel RL, Li MO, Flavell RA, Kronenberg M, Mackay IR, Gershwin ME. Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice. J Immunol 2006;177:1655-60. [PMID: 16849474 DOI: 10.4049/jimmunol.177.3.1655] [Cited by in Crossref: 187] [Cited by in F6Publishing: 173] [Article Influence: 11.7] [Reference Citation Analysis]
193 Chen YW, Li DG, Wu JX, Chen YW, Lu HM. Tetrandrine inhibits activation of rat hepatic stellate cells stimulated by transforming growth factor-beta in vitro via up-regulation of Smad 7. J Ethnopharmacol. 2005;100:299-305. [PMID: 15905052 DOI: org/10.1016/j.jep.2005.03.027] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
194 Wang C, Liu Q, Huang Q, Liu J, He Y, Lu J, Bai X. Activation of PPARγ is required for hydroxysafflor yellow A of Carthamus tinctorius to attenuate hepatic fibrosis induced by oxidative stress. Phytomedicine 2013;20:592-9. [DOI: 10.1016/j.phymed.2013.02.001] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
195 Sobral LM, Montan PF, Zecchin KG, Martelli-Junior H, Vargas PA, Graner E, Coletta RD. Smad7 blocks transforming growth factor-β1-induced gingival fibroblast-myofibroblast transition via inhibitory regulation of Smad2 and connective tissue growth factor. J Periodontol. 2011;82:642-651. [PMID: 21054221 DOI: 10.1902/jop.2010.100510] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
196 Bolkenius U, Hahn D, Gressner AM, Breitkopf K, Dooley S, Wickert L. Glucocorticoids decrease the bioavailability of TGF-beta which leads to a reduced TGF-beta signaling in hepatic stellate cells. Biochem Biophys Res Commun. 2004;325:1264-1270. [PMID: 15555563 DOI: 10.1016/j.bbrc.2004.10.164] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 2.2] [Reference Citation Analysis]
197 Treviño-Villarreal JH, Reynolds JS, Langston PK, Thompson A, Mitchell JR, Franco RA Jr. Down-Regulation of a Profibrotic Transforming Growth Factor-β1/Cellular Communication Network Factor 2/Matrix Metalloprotease 9 Axis by Triamcinolone Improves Idiopathic Subglottic Stenosis. Am J Pathol 2021;191:1412-30. [PMID: 34111429 DOI: 10.1016/j.ajpath.2021.05.013] [Reference Citation Analysis]
198 Weng HL, Liu Y, Chen JL, Huang T, Xu LJ, Godoy P, Hu JH, Zhou C, Stickel F, Marx A. The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesis. Hepatology. 2009;50:230-243. [PMID: 19441105 DOI: 10.1002/hep.22934] [Cited by in Crossref: 89] [Cited by in F6Publishing: 90] [Article Influence: 6.8] [Reference Citation Analysis]
199 Fan S, Weng CF. Co-administration of cyclosporine A alleviates thioacetamide-induced liver injury. World J Gastroenterol 2005; 11(10): 1411-1419 [PMID: 15770714 DOI: 10.3748/wjg.v11.i10.1411] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
200 Ye Z, Houssein HS, Mahato RI. Bioconjugation of oligonucleotides for treating liver fibrosis. Oligonucleotides 2007;17:349-404. [PMID: 18154454 DOI: 10.1089/oli.2007.0097] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]